|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Share-based compensation | |||||
| Impairment of long-lived assets | |||||
| Restructuring charges | |||||
| Goodwill impairment | |||||
| Operating income (loss) | |||||
| Other expenses: | |||||
| Interest expense, net | |||||
| Gain on insurance recoveries | |||||
| Loss on debt extinguishment and modification | |||||
| Total other expenses | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Comprehensive income (loss) | |||||
| Basic earnings (net loss) per share (in usd per share) | |||||
| Diluted earnings (net loss) per share (in usd per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
